Recombinant Anti-SARS-CoV-2 Spike RBD antibody (CR3022), Clone: [CR3022], Human, Monoclonal

Product Overview

• Article Name: Recombinant Anti-SARS-CoV-2 Spike RBD antibody (CR3022), Clone: [CR3022], Human, Monoclonal
• Biozol Catalog Number: ABI-10-2004
• Supplier Catalog Number: 10-2004
• Alternative Catalog Number: ABI-10-2004-100UG
• Manufacturer: Abeomics
• Host: Human
• Category: Antikörper
• Application: ELISA, FA
• Immunogen: Tissue, cells or virus corresponding to Human coronavirus SARS-CoV-2 Spike Glycoprotein S1. The original monoclonal antibody was generated by sequencing peripheral blood lymphocytes of a patient exposed to the SARS-CoV.
• Alternative Names: COVID19, NCOV, COV-2, COV2, COVID, SARS-COV, SARS-COV-2, COVID-19, CORONA

Product Description

The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, dipeptidyl peptidase-4, APN, aminopeptidase N, CEACAM, ca

Product Properties

• Clonality: Monoclonal
• Clone Designation: [CR3022]
• Isotype: Human IgG1 kappa
• UniProt: P0DTC2
• Buffer: 0.5 mg/ml, 100 µg in sterile PBS
• Purity: Affinity purified
• Formula: 0.5 mg/ml, 100 ug in sterile PBS
• Target: Spike S1